Smoking Status Inversely Linked to Primary Sjogren Syndrome
Data show that current smoking status was inversely associated with primary Sjogren syndrome.
Research
PAH: An Under-Recognized Complication of Adult-Onset Still’s Disease
PAH is an under-diagnosed complication of adult-onset Still disease.
Efficacy of Low-Dose Interleukin-2 Examined Across Autoimmune Diseases
Researchers assessed the safety, biologic, and clinical effects of low-dose interleukin-2 across 11 individual diseases chosen to represent the whole spectrum of autoimmune or inflammatory chronic diseases.
TNFi Treatment Patterns Examined Among Pregnant Women
Using a validated claims-based algorithm, study authors identified pregnancies among women 15-54 years of age from the US Sentinel System between January 1 2004 and September 30 2015.
Synovial Biopsy Analysis in Rheumatic Disease: Consensus Items Developed by EULAR, OMERACT
A set of analysis items has been developed by the EULAR Synovitis Study Group and the OMERACT Synovial Tissue Biopsy Group for the analysis of synovial biopsies in rheumatic diseases.
Tocilizumab May Be Effective for the Treatment of Adult-Onset Still’s Disease
Researchers examined the efficacy and safety of tocilizumab in patients with adult-onset Still’s disease.
Cardiovascular Health Risks Identified With Diclofenac Use
To investigate the cardiovascular risks associated with diclofenac, researchers conducted a series of cohort studies mimicking the design criteria of a clinical trial.
B-Cell Biomarkers Linked to Disease Activity Indicators in Primary Sjogren Syndrome
Three biomarkers related to B-cell activity were associated with various domains of the European League Against Rheumatism Sjogren Syndrome Disease Activity Index.
Efficacy, Safety of Biologics Assessed in Relapsing Polychondritis
Researchers sought to describe the efficacy of biologics for refractory relapsing polychondritis.
Precision Medicine in Rheumatology: Personalizing Treatment for Improved Clinical Outcomes
Judith A. James, MD, PhD, discusses the developments of precision medicine in rheumatology at the 2018 State-of-the-Art Clinical Symposium.
Next post in Research
